82 related articles for article (PubMed ID: 24025158)
1. STEAP1 protein overexpression is an independent marker for biochemical recurrence in prostate carcinoma.
Ihlaseh-Catalano SM; Drigo SA; de Jesus CM; Domingues MA; Trindade Filho JC; de Camargo JL; Rogatto SR
Histopathology; 2013 Nov; 63(5):678-85. PubMed ID: 24025158
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of STEAP1 extracellular vesicles in prostate cancer.
Khanna K; Salmond N; Lynn KS; Leong HS; Williams KC
Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):802-811. PubMed ID: 33589770
[TBL] [Abstract][Full Text] [Related]
3. [miR-129 in the diagnosis, treatment and prediction of clinical prognosis of prostate cancer].
Zhao XD; Tang ZL; Wang ZH; Dong J; Xu S
Zhonghua Nan Ke Xue; 2022 Nov; 28(11):996-1005. PubMed ID: 37846115
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Stability of Detergent-Free Human Native STEAP1 Protein from Neoplastic Prostate Cancer Cells upon an Innovative Isolation Procedure.
Barroca-Ferreira J; Cruz-Vicente P; Santos MFA; Rocha SM; Santos-Silva T; Maia CJ; Passarinha LA
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576175
[TBL] [Abstract][Full Text] [Related]
5. Six Transmembrane Epithelial Antigen 1 as a Prognostic Biomarker in Carcinomas: A Meta-Analysis.
Zhao S; Chen H; Zhou Y; Wang Q; Liang X; Yang N; Yan L; Yang J
Front Biosci (Landmark Ed); 2023 Nov; 28(11):280. PubMed ID: 38062846
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of stepwise electron transfer in six-transmembrane epithelial antigen of the prostate (STEAP) 1 and 2.
Chen K; Wang L; Shen J; Tsai AL; Zhou M; Wu G
Elife; 2023 Nov; 12():. PubMed ID: 37983176
[TBL] [Abstract][Full Text] [Related]
7. Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients.
Gonnissen A; Isebaert S; Perneel C; McKee CM; Van Utterbeeck F; Lerut E; Verrill C; Bryant RJ; Joniau S; Muschel RJ; Haustermans K
Am J Pathol; 2018 Mar; 188(3):795-804. PubMed ID: 29339090
[TBL] [Abstract][Full Text] [Related]
8. CYP7B1 as a Biomarker for Prostate Cancer Risk and Progression: Metabolic and Oncogenic Signatures (Diagnostic Immunohistochemistry Analysis by Tissue Microarray in Prostate Cancer Patients-Diamond Study).
Russo GI; Durukan E; Asmundo MG; Lo Giudice A; Salzano S; Cimino S; Rescifina A; Fode M; Abdelhameed AS; Caltabiano R; Broggi G
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731981
[TBL] [Abstract][Full Text] [Related]
9. High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patients.
Grunewald TGP; Ranft A; Esposito I; da Silva-Buttkus P; Aichler M; Baumhoer D; Schaefer KL; Ottaviano L; Poremba C; Jundt G; Jürgens H; Dirksen U; Richter GHS; Burdach S
Ann Oncol; 2012 Aug; 23(8):2185-2190. PubMed ID: 22317770
[TBL] [Abstract][Full Text] [Related]
10. AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer.
Nolan-Stevaux O; Li C; Liang L; Zhan J; Estrada J; Osgood T; Li F; Zhang H; Case R; Murawsky CM; Estes B; Moore GL; Bernett MJ; Muchhal U; Desjarlais JR; Staley BK; Stevens J; Cooke KS; Aeffner F; Thomas O; Stieglmaier J; Lee JL; Coxon A; Bailis JM
Cancer Discov; 2024 Jan; 14(1):90-103. PubMed ID: 37861452
[TBL] [Abstract][Full Text] [Related]
11. The expression of YWHAZ and NDRG1 predicts aggressive outcome in human prostate cancer.
Lage-Vickers S; Bizzotto J; Valacco MP; Sanchis P; Nemirovsky S; Labanca E; Scorticati C; Mazza O; Mitrofanova A; Navone N; Vazquez E; Cotignola J; Gueron G
Commun Biol; 2021 Jan; 4(1):103. PubMed ID: 33483585
[TBL] [Abstract][Full Text] [Related]
12. Targeting STEAP1 as an anticancer strategy.
Nakamura H; Arihara Y; Takada K
Front Oncol; 2023; 13():1285661. PubMed ID: 37909017
[TBL] [Abstract][Full Text] [Related]
13. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel vascular targets in lung cancer.
Zhuang X; Herbert JM; Lodhia P; Bradford J; Turner AM; Newby PM; Thickett D; Naidu U; Blakey D; Barry S; Cross DA; Bicknell R
Br J Cancer; 2015 Feb; 112(3):485-94. PubMed ID: 25535734
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgens.
Gomes IM; Rocha SM; Gaspar C; Alvelos MI; Santos CR; Socorro S; Maia CJ
Med Oncol; 2018 Feb; 35(3):40. PubMed ID: 29464393
[TBL] [Abstract][Full Text] [Related]
16. Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges.
Barroca-Ferreira J; Pais JP; Santos MM; Goncalves AM; Gomes IM; Sousa I; Rocha SM; Passarinha LA; Maia CJ
Curr Cancer Drug Targets; 2018; 18(3):222-230. PubMed ID: 28460619
[TBL] [Abstract][Full Text] [Related]
17. Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using
Carrasquillo JA; Fine BM; Pandit-Taskar N; Larson SM; Fleming SE; Fox JJ; Cheal SM; O'Donoghue JA; Ruan S; Ragupathi G; Lyashchenko SK; Humm JL; Scher HI; Gönen M; Williams SP; Danila DC; Morris MJ
J Nucl Med; 2019 Nov; 60(11):1517-1523. PubMed ID: 31053681
[TBL] [Abstract][Full Text] [Related]
18. Utilisation of the STEAP protein family in a diagnostic setting may provide a more comprehensive prognosis of prostate cancer.
Burnell SEA; Spencer-Harty S; Howarth S; Bodger O; Kynaston H; Morgan C; Doak SH
PLoS One; 2019; 14(8):e0220456. PubMed ID: 31393902
[TBL] [Abstract][Full Text] [Related]
19. Cryo-electron microscopy structure and potential enzymatic function of human six-transmembrane epithelial antigen of the prostate 1 (STEAP1).
Oosterheert W; Gros P
J Biol Chem; 2020 Jul; 295(28):9502-9512. PubMed ID: 32409586
[TBL] [Abstract][Full Text] [Related]
20. Six-transmembrane epithelial antigen of the prostate 1 is associated with tumor invasion and migration in endometrial carcinomas.
Sun J; Ji G; Xie J; Jiao Z; Zhang H; Chen J
J Cell Biochem; 2019 Jul; 120(7):11172-11189. PubMed ID: 30714206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
